Six-Month Surgical Outcomes of Ahmed ClearPath™ ST250 Implantation in Seven Eyes With Refractory Glaucoma: A Case Series
It is suggested that Ahmed ClearPath™ ST250 might be a useful surgical option for the management of refractory glaucoma and five of seven patients were glaucoma medication-free after surgery at six months.